Japanese government Amoy Diagnostics, Amgen Partner on Lung Cancer CDx Development for Lumakras in Japan Amoy Diagnostics will develop its PCR-based panel as a companion diagnostic in Japan to screen NSCLC patients for Amgen's KRAS G12C inhibitor. Amoy Diagnostics CDx Gets Japanese Approval to ID NSCLC Patients Eligible for Tepmetko The Japanese Ministry of Health, Labor, and Welfare has approved AmoyDx's PLC Panel for use in identifying NSCLC patients with MET exon 14 skipping alterations. Japanese Regulator Approves Foundation Medicine CDx for Roche's Rozlytrek in Lung Cancer The approval will allow clinicians to identify NSCLC patients with ROS1 fusion genes who could benefit from treatment with Rozlytrek. Myriad Genetics BRACAnalysis Approved by Japanese Regulators Doctors can now order the test to identify breast cancer patients with BRCA1/2 mutations who may be eligible for surgery or targeted therapy. Merck, Promega Collaborate to Develop MSI CDx for Keytruda Promega's microsatellite instability technology will be used to develop an on-label, solid tumor companion diagnostic for pembrolizumab. Oct 9, 2019 Japanese Informatics Firm Genomedia Sees SCRUM Cancer Project as Path to Wider Adoption Premium Jul 3, 2019 Japan, China Launch Basket, Umbrella Trials to Expand Precision Oncology Treatment Access Premium Jun 19, 2019 Japanese Regulators Approve Invivoscribe Assay as CDx for Daiichi Sankyo AML Drug Feb 3, 2017 Japan Regulators Approve AmoyDx's Lung Cancer CDx Apr 28, 2009 RIKEN Omics Science Center to Expand Sequencing Facility with $17M in Government Funding Premium Breaking News GenomeWeb Index Falls 6 Percent in November as Emergence of Omicron Spooks Markets Sequencing-Based MRD Detection in Bone Marrow May Predict ALL Relapse After CAR T-Cell Therapy Metabolomic Study Links 13 Metabolites to Coronary Heart Disease Risk Among African Americans Illumina Wins $8M Jury Verdict in BGI Patent Infringement Suit, Loses Patent Caris Life Sciences Facing FTC Lawsuit After Resisting Subpoena in Illumina, Grail Antitrust Case Biodesix, Spesana Partner to Improve Workflows for Lung Cancer Molecular Diagnostic Tests The Scan Panel Votes for COVID-19 Pill A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says. But Not Harm New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare. Effectiveness Drop Anticipated Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports. Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.